1Beale RJ, Bryg DJ, Bihafi DJ. Immunonutrition in the critically ill:a systematic review of clinical outoome[J]. Crit Care Med, 1999,27( 12):2799 - 805.
2Neu J. Glutamine in the fetus and critically ill low birth weight neonate: metabolism and mechanism of action[J]. J Nutr, 2001,131(9 Suppl):2585S- 9S.
3Wischmeyer PE, Lynch J, Lied.el J, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control[J]. Crit Care Med, 2001,29(11):2075-80.
4Houdijk AP, Rijnsburger ER, Jansen J, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple traurna[J]. Lancet, 1998,352(9130):772-6.
5Neu J, Roig JC, Meetze WH, et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity[J]. J Pediatr,1997,131(5):691-9.
6Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine reduces cytokine release, organ damage, and mortality in a rat model ofendotoxemia[J]. Shock, 2001,16(5):398-402.
7Coeffier M, Miralles- Batrachina O, Le Pessot F, et al. Influence ofglutamine on cytokine production by human gut in vitro[J].Cytokine, 2001,13(3):148- 54.
8Fukatsu K, Kudsk KA, Zarzaur BL, et al. TPN decreased IL-4 andIL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression[J]. Shock, 2001,15(4):318-22.
9Hebiguchi T, Kato T, Yoshino H, et al. The effect of argirtine supplementation on growth hormone release and intestinal mucosal growth after massive small bowel resection in growing rats[J], J PediatrSurg, 1997,32(8): 1149- 53.
10Becker RM, Wu G, Galanko JA, et al, Reduced serum amino acid concentrations in infants with necrotiring enterooolitis[J], J Pediatr,2000,137(6):785-93.
